[ Price : $8.95]
FDA accepts a Bayer BLA for BAY94-9027, an extended half-life PEGylated recombinant human Factor VIII compound for treating hemoph...[ Price : $8.95]
Federal Register notice: FDA seeks nominations for a nonvoting industry representative to serve on its Pediatric Advisory Committe...[ Price : $8.95]
Federal Register notice: FDA announces an 11/30 public meeting on Assessment of FDA Hiring and Retention that will share high-leve...[ Price : $8.95]
CDRH senior science advisor Heather Agler suggests that medical device manufacturers design their products with interoperability a...[ Price : $8.95]
FDA approves a Bausch + Lomb and Nicox NDA for Vyzulta (latanoprostene bunod ophthalmic solution, 0.024%), indicated for reducing ...[ Price : $8.95]
Pfizer officials say they have submitted a corrective and preventative action plan to FDA on remediating GMP issues at Hospira leg...[ Price : $8.95]
The Lancet Oncology Commission outlines future cancer research priorities for the U.S. Cancer Moonshot.[ Price : $8.95]
Members of two FDA advisory committees vote to recommend approval of Indiviors RBP-6000 for treating adults with opioid use disord...